ATRenew to Attend Goldman Sachs TechNet Conference Asia Pacific 2024
PR Newswire Asia
SHANGHAI, May 7, 2024 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned..
SHANGHAI, May 7, 2024 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned..
OJEMDA™ (tovorafenib) launch underway following U.S. FDA accelerated approval for relapsed or refractory BRAF-altered Pediatric..
In the past one year, half the new customers that we have added are all pure play quick commerce customers, who often do not make..